FINWIRES · TerminalLIVE
FINWIRES

研究快讯:波音第一季度业绩超预期,交付量增长,现金流接近盈亏平衡。

-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:波音公司第一季度业绩显示复苏进展顺利,运营现金流同比增长14亿美元至-2亿美元,营收增长14%至222亿美元(高于市场预期的3.05亿美元),调整后每股收益为-0.20美元,高于去年同期的-0.49美元(高于市场预期的-0.67美元)。波音交付了143架商用飞机(同比增长10%),737飞机的月产量维持在42架,同时787飞机的月产量提升至8架。我们认为波音的运营复苏正在稳步推进,尽管在复苏初期阶段执行风险仍然较高。管理层维持2026年自由现金流10亿至30亿美元的预期不变,剔除历史遗留不利因素后,调整后的年化增长率将达到接近两位数。商用飞机利润率为-6.1%,反映了产能爬坡方面的挑战;要实现正利润,关键在于737和787的月产量能否按计划分别提高至47架和10架。国防业务利润率提升至3.1%,创纪录的850亿美元积压订单为未来几年的发展提供了保障。5760亿美元的商用飞机积压订单以及777X的认证进展将推动营收加速增长,但能否在2028-2029年实现100亿美元的年度自由现金流目标,关键在于交付时间。

Related Articles

Asia

Easou Technology Invests $7.7 Million in Wealth Product Using Idle Top-up Placing Funds

Easou Technology (HKG:2550) said it has subscribed to a $7.7 million wealth management product issued by Huatai International Financial Products, using idle proceeds from its earlier placings, according to a Friday Hong Kong bourse filing.Shares of the digital service firm were down over 1% in Monday's late-morning trade.The investment, guaranteed by Huatai International Financial, carries an annualized return of 1.07% to 5.83% over a term ending March 30, 2027.Easou said the move aims to enhance the utilization efficiency and returns on idle funds while maintaining liquidity.

$HKG:2550
Asia

SSY Group Gets Chinese Regulatory Nod for Production, Registration of Two Products

SSY Group (HKG:2005) said it received Chinese regulatory approval to begin drug production and registration of its diltiazem hydrochloride in injection form, according to a Hong Kong bourse filing Monday.The drug is mainly used to treat a heart condition known as supraventricular tachycardia and the emergency treatment of abnormally high blood pressure during surgery.The firm's propranolol hydrochloride injection was also approved for production and registration by China's National Medical Products Administration.The product is mainly used to treat supraventricular tachyarrhythmias and ventricular arrhythmias.

$HKG:2005
Asia

Amplitude Energy Says Australian Retirement Trust Raises Stake

Amplitude Energy (ASX:AEL) said Australian Retirement Trust raised its stake in the firm to 6.3% as of Friday from 5.1% as of April 2, according to a Monday Australian bourse filing.Australian Retirement Trust now holds nearly 19 million votes in the firm.

$ASX:AEL